A story of evidence-based medicine: Hormone replacement therapy and coronary heart disease in postmenopausal women

CHANCE - Tập 23 - Trang 52-56 - 2011
Arlene S. Swern

Tài liệu tham khảo

Gabriel Sanchez, R., L. M. Sanchez Gomez, L. Carmona, M. Roqué i Figuls, and X. Bonfill Cosp. 2005. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002229. DOI: 10.1002/14651858.CD002229.pub2. Hemminki, E., and K. McPherson. 1997. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials. BMJ 315:149–153. Hulley, S., D. Grady, T. Bush, et al. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605–613. Nurses’ Health Study. 1997. Postmenopausal hormone therapy and mortality. New Engl J Med 336:1769–1775. Salpeter, S. R., J. Walsh, E. Greyber, et al. 2004. Mortality associated with hormone replacement therapy in younger and older women, a meta-analysis. J Gen Intern Med 19:791–804. Salpeter, S. R., J. Walsh, E. Greyber, et al. 2006. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women, a meta-analysis. J Gen Intern Med 21:363–366. Stampfer, M. J., and G. A. Colditz. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Medicine 20:47–63. Sutton, A. L., K. R. Abrams, D. R. Jones, T. A. Sheldon, and F. Song. 2000. Methods for meta-analysis in medical research. London, United Kingdom: John Wiley & Sons. Toh, S., S. Hernandez-Diaz, R. Logan, et al. 2010. CHD in postmenopausal recipients of estrogen plus progestin therapy: Does the increased risk ever disappear? A randomized trial. Ann. Intern Med 152:211–217. Whitehead, A. 2002. Meta-analysis of controlled clinical trials. New York: John Wiley and Sons. Writing Group for the Women’s Health Initiative Investigators. 2002. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 299:321–333.